Prospective Cohort of Opiate Dependent Patients on Buprenorphine/Naloxone for Maintenance
Not Applicable
Completed
- Conditions
- Opiate Dependence
- Interventions
- Other: Mobile Access
- Registration Number
- NCT00622596
- Lead Sponsor
- Yale University
- Brief Summary
The purpose of this study was to expand access to buprenorphine using a mobile health care system among marginalized populations with or at high risk for HIV and observe longitudinal effects of treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
- HIV +
- At high risk for HIV (IV drug use, commercial sex worker, partner of HIV+)
- Mental Health (unmanaged or diagnosed mental illness)
Exclusion Criteria
- Benzodiazepine use
- Opiate use due to pain management issues only (present or past)
- Non-IDU
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Mobile Access to Buprenorphine Mobile Access High risk populations accessing a mobile health care system can obtain Buprenorphine for treatment.
- Primary Outcome Measures
Name Time Method Opioid free urine toxicology 10/1/03-9/30/08 To assess the feasibility and efficacy of the use of buprenorphine to treat opioid dependence in high risk populations accessing a mobile health care system using incidence of opioid free urine toxicology.
Attendance 10/1/03-9/30/08 To assess the feasibility and efficacy of the use of buprenorphine to treat opioid dependence in high risk populations accessing a mobile health care system using tracked attendance.
- Secondary Outcome Measures
Name Time Method Access to other health care, incarceration, hospitalization acceptability of the site of care from both patient and provider perspectives, and attendance and adherence to counseling. 10/1/03-9/30/08
Trial Locations
- Locations (1)
Yale University School of Medicine
🇺🇸New Haven, Connecticut, United States